Skip to content

Clinical trials

Active, not recruiting Mesothelioma, Malignant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Status: Active, not recruiting Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20161
20174
20182
20193
20202
20213
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Memorial Sloan Kettering Cancer Center3
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS2
M.D. Anderson Cancer Center2
AstraZeneca1
Checkpoint Therapeutics, Inc.1
Hyogo Medical University1
Istituto Oncologico Veneto IRCCS1
MedImmune LLC1
TCR2 Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant20
Lung Neoplasms3
Mesothelioma3
Carcinoma, Merkel Cell2
Carcinoma, Non-Small-Cell Lung2
Neoplasms2
Ovarian Neoplasms2
Adenocarcinoma, Mucinous1
Adenoma, Islet Cell1
Carcinoma, Neuroendocrine1

Trials

Showing 51 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.